Brief: Medmix H1 Adjusted EBITDA CHF 46 Million
Jul 18 (Reuters) - Medmix H1 adjusted EBITDA margin 19.1%. * H1 revenue CHF 241.2 million * outlook FY adjusted EBITDA margin 18-19%
Jul 18 (Reuters) - Medmix H1 adjusted EBITDA margin 19.1%. * H1 revenue CHF 241.2 million * outlook FY adjusted EBITDA margin 18-19%